EH301 for the Treatment of ALS

NCT03489200 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
32
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Elysium Health

Collaborators